Fulgent Genetics (FLGT) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Fulgent Genetics (FLGT) over the last 10 years, with Q3 2025 value amounting to -$0.21.
- Fulgent Genetics' EPS (Weighted Average and Diluted) rose 5625.0% to -$0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.39, marking a year-over-year increase of 7481.88%. This contributed to the annual value of -$1.41 for FY2024, which is 7495.56% up from last year.
- Per Fulgent Genetics' latest filing, its EPS (Weighted Average and Diluted) stood at -$0.21 for Q3 2025, which was up 5625.0% from -$0.62 recorded in Q2 2025.
- Fulgent Genetics' EPS (Weighted Average and Diluted)'s 5-year high stood at $6.52 during Q1 2021, with a 5-year trough of -$4.3 in Q4 2023.
- Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$0.29 (2024), whereas its average is $0.67.
- As far as peak fluctuations go, Fulgent Genetics' EPS (Weighted Average and Diluted) soared by 734444.44% in 2021, and later tumbled by 83333.33% in 2023.
- Over the past 5 years, Fulgent Genetics' EPS (Weighted Average and Diluted) (Quarter) stood at $3.35 in 2021, then crashed by 123.23% to -$0.78 in 2022, then crashed by 453.02% to -$4.3 in 2023, then skyrocketed by 95.58% to -$0.19 in 2024, then fell by 10.53% to -$0.21 in 2025.
- Its last three reported values are -$0.21 in Q3 2025, -$0.62 for Q2 2025, and -$0.37 during Q1 2025.